1. Home
  2. HESM vs PCVX Comparison

HESM vs PCVX Comparison

Compare HESM & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HESM
  • PCVX
  • Stock Information
  • Founded
  • HESM 2014
  • PCVX 2013
  • Country
  • HESM United States
  • PCVX United States
  • Employees
  • HESM N/A
  • PCVX N/A
  • Industry
  • HESM Oil & Gas Production
  • PCVX Biotechnology: Pharmaceutical Preparations
  • Sector
  • HESM Energy
  • PCVX Health Care
  • Exchange
  • HESM Nasdaq
  • PCVX Nasdaq
  • Market Cap
  • HESM 5.0B
  • PCVX 4.4B
  • IPO Year
  • HESM N/A
  • PCVX 2020
  • Fundamental
  • Price
  • HESM $40.29
  • PCVX $36.63
  • Analyst Decision
  • HESM Buy
  • PCVX Strong Buy
  • Analyst Count
  • HESM 5
  • PCVX 10
  • Target Price
  • HESM $46.20
  • PCVX $136.50
  • AVG Volume (30 Days)
  • HESM 1.6M
  • PCVX 1.5M
  • Earning Date
  • HESM 07-30-2025
  • PCVX 08-05-2025
  • Dividend Yield
  • HESM 7.05%
  • PCVX N/A
  • EPS Growth
  • HESM 15.91
  • PCVX N/A
  • EPS
  • HESM 2.55
  • PCVX N/A
  • Revenue
  • HESM $1,521,900,000.00
  • PCVX N/A
  • Revenue This Year
  • HESM $12.94
  • PCVX N/A
  • Revenue Next Year
  • HESM $11.19
  • PCVX N/A
  • P/E Ratio
  • HESM $15.82
  • PCVX N/A
  • Revenue Growth
  • HESM 8.77
  • PCVX N/A
  • 52 Week Low
  • HESM $33.59
  • PCVX $27.66
  • 52 Week High
  • HESM $44.05
  • PCVX $121.06
  • Technical
  • Relative Strength Index (RSI)
  • HESM 59.92
  • PCVX 57.48
  • Support Level
  • HESM $38.55
  • PCVX $35.25
  • Resistance Level
  • HESM $41.16
  • PCVX $37.95
  • Average True Range (ATR)
  • HESM 0.89
  • PCVX 1.55
  • MACD
  • HESM 0.16
  • PCVX 0.13
  • Stochastic Oscillator
  • HESM 75.49
  • PCVX 77.51

About HESM Hess Midstream LP Share

Hess Midstream LP owns, operates, develops, and acquires a diverse set of midstream assets and provides fee-based services to Hess and third-party customers. It conducts its business through three operating segments: gathering, processing and storage, and terminaling and exporting. The company derives the maximum revenue from the gathering segment. Its gathering segment consists of the following assets namely Natural Gas Gathering and Compression; Crude Oil Gathering and Produced Water Gathering and Disposal.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

Share on Social Networks: